Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013–2015
Authors:
Open Access
- 8 April 2017
- journal article
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 21 (3) , 343-348
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011Pharmaceuticals, 2013
- Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011)The Brazilian Journal of Infectious Diseases, 2013
- One-Year Surveillance of ESKAPE Pathogens in an Intensive Care Unit of Monterrey, MexicoChemotherapy, 2012
- The Challenges of Antimicrobial Resistance in BrazilClinical Infectious Diseases, 2011
- The rising problem of antimicrobial resistance in the intensive care unitAnnals of Intensive Care, 2011
- Progress and Challenges in Implementing the Research on ESKAPE PathogensInfection Control & Hospital Epidemiology, 2010
- Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2010
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPEThe Journal of Infectious Diseases, 2008
- In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART)Journal of Antimicrobial Chemotherapy, 2005